Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Karen M. Dunn"'
Autor:
Hannah Donnelly, Ewan Ross, Yinbo Xiao, Rio Hermantara, Aqeel F. Taqi, W. Sebastian Doherty-Boyd, Jennifer Cassels, Penelope. M. Tsimbouri, Karen M. Dunn, Jodie Hay, Annie Cheng, R. M. Dominic Meek, Nikhil Jain, Christopher West, Helen Wheadon, Alison M. Michie, Bruno Peault, Adam G. West, Manuel Salmeron-Sanchez, Matthew J. Dalby
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-18 (2024)
Abstract Long-term reconstituting haematopoietic stem cells (LT-HSCs) are used to treat blood disorders via stem cell transplantation. The very low abundance of LT-HSCs and their rapid differentiation during in vitro culture hinders their clinical ut
Externí odkaz:
https://doaj.org/article/e8984c0b474a49c1b8fa3b60f306f23a
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Suppl Table 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2c4f897bd11f1a4e98767a3e75b12a5
https://doi.org/10.1158/1078-0432.22472681.v1
https://doi.org/10.1158/1078-0432.22472681.v1
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Suppl Figure 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8da5104547ba7376bf923db23e33f3fd
https://doi.org/10.1158/1078-0432.22472702
https://doi.org/10.1158/1078-0432.22472702
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Suppl Figure 3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f8cd1339459427f4fa868e5f2d96224
https://doi.org/10.1158/1078-0432.22472699.v1
https://doi.org/10.1158/1078-0432.22472699.v1
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Suppl Figure 7
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a76fb5a12fa22dae21d498da22adeb5
https://doi.org/10.1158/1078-0432.22472687.v1
https://doi.org/10.1158/1078-0432.22472687.v1
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Purpose:To determine whether inhibition of mTOR kinase-mediated signaling represents a valid therapeutic approach for chronic lymphocytic leukemia (CLL).Experimental Design:Stratification of mTOR activity was carried out in patients with primary CLL
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f4c170bcbd5ba0e57d1e4867af9e944
https://doi.org/10.1158/1078-0432.c.6528299
https://doi.org/10.1158/1078-0432.c.6528299
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Suppl Figure 4
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55350c8422e97d15213a7549da051e37
https://doi.org/10.1158/1078-0432.22472696.v1
https://doi.org/10.1158/1078-0432.22472696.v1
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Suppl Figure 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08ac16f8e8fc30890d057ee4e8122fa6
https://doi.org/10.1158/1078-0432.22472705.v1
https://doi.org/10.1158/1078-0432.22472705.v1
Autor:
Alison M. Michie, Alison M. McCaig, Sabina C. Cosulich, Owen J. Sansom, Michael T. Leach, Declan O'Rourke, Sylvie M. Guichard, Alan M. Macdonald, Karen M. Dunn, Jodie Hay, Mark A. Catherwood, Natasha Malik, Ailsa K. Holroyd, Michael W. Moles, Anuradha Tarafdar, Emilio Cosimo
Suppl Figure 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f14e321479bb57213cca84cafc70a8a
https://doi.org/10.1158/1078-0432.22472693
https://doi.org/10.1158/1078-0432.22472693
Autor:
Jodie Hay, Anuradha Tarafdar, Ailsa K. Holroyd, Hothri A. Moka, Karen M. Dunn, Alzahra Alshayeb, Bryony H. Lloyd, Jennifer Cassels, Natasha Malik, Ashfia F. Khan, IengFong Sou, Jamie Lees, Hassan N. B. Almuhanna, Nagesh Kalakonda, Joseph R. Slupsky, Alison M. Michie
Publikováno v:
Cancers; Volume 14; Issue 23; Pages: 6006
B cell antigen receptor (BCR) signaling competence is critical for pathogenesis of chronic lymphocytic leukemia (CLL). Defining key proteins that facilitate these networks aid in the identification of targets for therapeutic exploitation. We previous
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0f757ca5ccc8c7e10524dd303c697216
https://doi.org/10.1101/2022.09.04.506520
https://doi.org/10.1101/2022.09.04.506520